PORTLAND, Maine–(BUSINESS WIRE)–Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that healthcare and pharmaceutical veteran Pete Perron has joined the company as president of strategic partnerships with responsibility for strategic partnerships with suppliers, global procurement and the management of the Company’s North American membership organizations. In this new role, Pete will look to leverage the Company’s differentiated set of capabilities and significant customer reach, including its membership organizations, to help the Company’s manufacturer partners achieve their strategic objectives while delivering enhanced outcomes for the Company’s veterinary practice partners.
“We are excited to welcome Pete to the Covetrus team and for him to fill this role within the organization as we advance our mission to drive better care and outcomes for the global veterinary industry,” said Ben Wolin, president and CEO of Covetrus. “With more than 25 years of experience building strong relationships within pharmaceutical, healthcare, and wholesale market sectors, Pete is uniquely suited to lead our strategic partnerships and create incremental value and opportunities for our many customers and stakeholders.”
Prior to joining Covetrus, Pete worked at McKesson. Most recently he served as the president of Provider Solutions, where he led the 600+ team that helped specialty providers thrive, including distribution, GPO Services and practice efficiency tools, patient care, payer and clinical support. Prior to his time with McKesson, Perron held leadership roles within sales, marketing in the biopharmaceutical space, including at Pfizer and Janssen. He holds BA and MS degrees from the University of North Texas.
“Covetrus is at the center of helping veterinarians drive better health outcomes. The Company’s customer reach and distinctly comprehensive set of capabilities allow it to drive opportunity for all stakeholders—veterinarians, manufacturers and pet owners included,” said Pete Perron. “This is an exciting opportunity, and I look forward to working with the team to drive value for veterinarians and increasing access to a higher standard of care, while maximizing our ability to drive healthy business for manufacturer partners and our stakeholders.”
This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our plans, objectives, expectations, and intentions. Such statements are subject to numerous risks and uncertainties. Factors that could adversely affect our business and prospects are set forth in our public filings with the Securities and Exchange Commission. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.
Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We are bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine with more than 5,500 employees serving over 100,000 customers around the globe. For more information about Covetrus visit https://covetrus.com/.